Last month the National Diabetes Audit released its report of the prevelance of complications, the risk of death following a complication event and the general mortality of UK diabetics. The report can be viewed here:
http://www.hscic.gov.uk/catalogue/PUB12738/nati-diab-audi-11-12-mort-comp-rep.pdf
Some of you know that the NDA's HbA1c report highlighted just how poor the efficacy of UK diabetes is; with just 7% of Type 1s and 25% of Type 2s achieving the HbA1c efficacy target of 6.5%, where the risk of complications is at unity with the non-diabetic population. The Complications & Mortality report, is equally, if not, more grim. Here are the headlines:
Complication of Diabetes in England and Wales
Short term mortality
These plots are really interesting. They measure the odds of an individual dying a year after a complication event.
CKD
Overall Mortality
http://www.hscic.gov.uk/catalogue/PUB12738/nati-diab-audi-11-12-mort-comp-rep.pdf
Some of you know that the NDA's HbA1c report highlighted just how poor the efficacy of UK diabetes is; with just 7% of Type 1s and 25% of Type 2s achieving the HbA1c efficacy target of 6.5%, where the risk of complications is at unity with the non-diabetic population. The Complications & Mortality report, is equally, if not, more grim. Here are the headlines:
Complication of Diabetes in England and Wales
- Angina, heart attacks and heart failure were experienced by just over 10% of diabetics between April 2010 and March 2012. This would highlight to me the need for diabetics to take regular exercise and control their weight. I expect this statistic to be skewed by some of the Type 2s that are diabetic via lifestyle factors.
- The prevalence of DKA for Type 1s was 6%, which means that just over 1 in 20 Type 1s experienced DKA between April 2010 and March 2012.
- The additional risk (of a diabetic compared to a non-diabetic) of amputation and renal therapy is very startling, it’s quite remarkable to see such terribly high risk of these disorders. The risk of amputation is 336% and renal therapy is 164%.
Short term mortality
These plots are really interesting. They measure the odds of an individual dying a year after a complication event.
- A socio-economic measurement shows that people from the most deprived areas are more likely to die following a complication event. Conversely, people from the least deprived areas are less likely to die following a complication event.
- A very interesting find is that Type 1s with an HbA1c less than 51 mmol/mol (6.8%) have a higher risk of mortality following a complication event than someone with an HbA1c in the 61-70 mmol/mol range (7.7 - 8.6%). I know that sudden drops in HbA1c can make complications worse, so perhaps this is a manifestation of that and not that a low HbA1c is bad for you. This pattern is not true for Type 2s.
- As expected though, for both types, the worse your HbA1c the higher your risk of mortality following a complication event.
- The cholesterol plot is very interesting too. It seems a low cholesterol, particularly for Type 2s, below 3 is bad for mortality. A cholesterol level following a complication event that gives the best mortality rate is 4.1-5.0 for both Types.
- The least survivable complication is renal replacement therapy, followed by heart failure, stroke, DKA.
- The most survivable complication for both types is angina.
- It must be said though, that these mortality odds are very grim. With renal replacement therapy, a Type 1 is 8 times (Type 2 is 6 times) more likely to die than a Type 1 who hasn’t had any complication in the same period.
CKD
- The headline from this is that only 25% of diabetics have no CKD. I find this astonishing. Although the report says that it is CKD stages 3, 4 and 5 that require treatment. This means that the percentage of diabetics that require renal treatment is 18%. The 18% and the 25% don’t add to 100 because of a lack of data for 8% of patients.
Overall Mortality
- Overall mortality has slightly improved since the previous audit. Be aware that although mortality has improved, there may be survivor bias in the data. So, I don’t know whether it would be accurate to say that mortality rates have improved.
- Mortality for diabetics is significantly higher compared to non-diabetics. The additional risk of mortality for Type 1s is 130%, for Type 2s it is 35%.
- The mortality risk for Type 1s is therefore significantly higher than that for Type 2s.
- Type 1 and Type 2 females have a significantly greater risk of death than males. This is particularly true for Type 1 where females have a 27% greater risk of mortality than Type 1 males. Whereas for Type 2, females have a 10% greater risk of mortality than males.
- When it is broken down by age, the mortality risk is even more frightening. Type 1 females aged between 15 and 34 have a mortality risk 7 times more than a non-diabetic female in that age range. Males in that age range have 4 times the risk of non-diabetic males.
- These risks decrease with age. Probably because the poorly-controlled diabetics have died off, i.e. survivor bias
Last edited by a moderator: